Milestone Pharma Files Proxy Statement for June Meeting
Ticker: MIST · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1408443
| Field | Detail |
|---|---|
| Company | Milestone Pharmaceuticals Inc. (MIST) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: MMP
TL;DR
Milestone Pharma (MMP) proxy filed. Vote for directors on 6/10.
AI Summary
Milestone Pharmaceuticals Inc. filed its definitive proxy statement (DEF 14A) on April 30, 2025, for its annual meeting on June 10, 2025. The filing concerns the election of directors and other corporate governance matters. The company is based in Montreal, Canada, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership and voting matters, impacting their ability to influence corporate direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating immediate financial distress or significant new risks.
Key Numbers
- 20250430 — Filing Date (Date the DEF 14A was submitted to the SEC.)
- 20250610 — Meeting Date (Date of the shareholder meeting for which this proxy statement is issued.)
Key Players & Entities
- Milestone Pharmaceuticals Inc. (company) — Registrant
- 20250430 (date) — Filing Date
- 20250610 (date) — Meeting Date
- Montreal (location) — Company Headquarters
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting on June 10, 2025, including the election of directors and other corporate governance matters.
When was this proxy statement filed with the SEC?
This definitive proxy statement was filed on April 30, 2025.
Where is Milestone Pharmaceuticals Inc. headquartered?
Milestone Pharmaceuticals Inc. is headquartered in Montreal, Canada.
What is the Standard Industrial Classification (SIC) code for Milestone Pharmaceuticals Inc.?
The SIC code for Milestone Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Is there a fee associated with this filing?
No, the filing indicates that no fee was required for this DEF 14A filing.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Milestone Pharmaceuticals Inc. (MIST).